Literature DB >> 27059548

Effects of white matter integrity and brain volumes on late life depression in the Framingham Heart Study.

Wei Qiao Qiu1,2,3, Jayandra J Himali4,5, Philip A Wolf4,5, D Charles DeCarli6, Alexa Beiser4,5,7, Rhoda Au4,5.   

Abstract

BACKGROUND: It is unclear whether brain white matter hyperintensities (WMHI) causes or is a result of late life depression. We used the Framingham Heart Study offspring to examine whether indices of brain aging are related to incident depression in the elderly.
METHODS: The Center for Epidemiologic Studies Depression Scale (CES-D) was administered along with a brain MRI scan at baseline and was re-administered (n = 1212) at an average 6.6 + 0.6 year follow-up. The outcomes (i) change in CES-D scores from baseline; (ii) depression defined as CES-D ≥16; (iii) severe depression defined as CES-D ≥21; and (iv) CES-D cutoff scores and/or on antidepressant were used.
RESULTS: Among those who did not have depression at baseline, 9.1% (n = 110) developed depression, 4.0% (n = 48) developed severe depressive symptoms, and 11.1% (n = 135) were put on antidepressants. When depressive symptoms only was the outcome, we found that baseline WMHI was positively associated with change in CES-D scores and that those with an extensive WMHI at baseline had a high risk of developing severe depressive symptoms; the relationship was strengthened in the absence of cardiovascular diseases. In contrast, when depressive symptoms or taking antidepressant was the outcome, larger total cerebral brain volume and temporal lobe brain volume, but not WMHI, were negatively associated with the development of depression.
CONCLUSIONS: Brain WMHI is a probable risk factor for vascular depression in the elderly. The depression outcomes with and without antidepressant were related to different brain pathologies.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Framingham Heart Study; brain; late life depression; longitudinal; white matter hyperintensities

Mesh:

Year:  2016        PMID: 27059548      PMCID: PMC5052093          DOI: 10.1002/gps.4469

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  38 in total

Review 1.  Diagnosis and treatment of depression in late life. Consensus statement update.

Authors:  B D Lebowitz; J L Pearson; L S Schneider; C F Reynolds; G S Alexopoulos; M L Bruce; Y Conwell; I R Katz; B S Meyers; M F Morrison; J Mossey; G Niederehe; P Parmelee
Journal:  JAMA       Date:  1997-10-08       Impact factor: 56.272

2.  Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial.

Authors:  Yvette I Sheline; Carl F Pieper; Deanna M Barch; Kathleen Welsh-Bohmer; Kathleen Welsh-Boehmer; Robert C McKinstry; James R MacFall; Gina D'Angelo; Keith S Garcia; Kenneth Gersing; Consuelo Wilkins; Warren Taylor; David C Steffens; Ranga R Krishnan; P Murali Doraiswamy
Journal:  Arch Gen Psychiatry       Date:  2010-03

3.  Measures of brain morphology and infarction in the framingham heart study: establishing what is normal.

Authors:  Charles DeCarli; Joseph Massaro; Danielle Harvey; John Hald; Mats Tullberg; Rhoda Au; Alexa Beiser; Ralph D'Agostino; Philip A Wolf
Journal:  Neurobiol Aging       Date:  2005-04       Impact factor: 4.673

4.  Neuropsychological differences between late-onset and recurrent geriatric major depression.

Authors:  Michael A Rapp; Karen Dahlman; Mary Sano; Hillel T Grossman; Vahram Haroutunian; Jack M Gorman
Journal:  Am J Psychiatry       Date:  2005-04       Impact factor: 18.112

5.  Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study.

Authors:  C DeCarli; T Reed; B L Miller; P A Wolf; G E Swan; D Carmelli
Journal:  Stroke       Date:  1999-08       Impact factor: 7.914

6.  fMRI correlates of white matter hyperintensities in late-life depression.

Authors:  Howard J Aizenstein; Carmen Andreescu; Kathryn L Edelman; Jennifer L Cochran; Julie Price; Meryl A Butters; Jordan Karp; Meenal Patel; Charles F Reynolds
Journal:  Am J Psychiatry       Date:  2011-07-28       Impact factor: 18.112

7.  Recollection memory deficits in patients with major depressive disorder predicted by past depressions but not current mood state or treatment status.

Authors:  G M MacQueen; T M Galway; J Hay; L T Young; R T Joffe
Journal:  Psychol Med       Date:  2002-02       Impact factor: 7.723

8.  Does depression predict cognitive outcome 9 to 12 years later? Evidence from a prospective study of elderly hypertensives.

Authors:  J A Cervilla; M Prince; S Joels; A Mann
Journal:  Psychol Med       Date:  2000-09       Impact factor: 7.723

9.  White matter hyperintensity progression and late-life depression outcomes.

Authors:  Warren D Taylor; David C Steffens; James R MacFall; Douglas R McQuoid; Martha E Payne; James M Provenzale; K Ranga Rama Krishnan
Journal:  Arch Gen Psychiatry       Date:  2003-11

10.  Relationship between age at onset and magnetic resonance image-defined hyperintensities in mood disorders.

Authors:  K Takahashi; A Oshima; I Ida; H Kumano; N Yuuki; M Fukuda; M Amanuma; K Endo; M Mikuni
Journal:  J Psychiatr Res       Date:  2007-06-22       Impact factor: 4.791

View more
  7 in total

Review 1.  The enigma of vascular depression in old age: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2022-06-15       Impact factor: 3.850

2.  Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study.

Authors:  Mitzi M Gonzales; Jasmeet Samra; Adrienne O'Donnell; R Scott Mackin; Joel Salinas; Mini E Jacob; Claudia L Satizabal; Hugo J Aparicio; Emma G Thibault; Justin S Sanchez; Rebecca Finney; Zoe B Rubinstein; Danielle V Mayblyum; Ron J Killiany; Charlie S Decarli; Keith A Johnson; Alexa S Beiser; Sudha Seshadri
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

3.  Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study.

Authors:  Ryan J Piers; Yulin Liu; Ting F A Ang; Qiushan Tao; Rhoda Au; Wei Qiao Qiu
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

4.  Vascular depression consensus report - a critical update.

Authors:  Howard J Aizenstein; Andrius Baskys; Maura Boldrini; Meryl A Butters; Breno S Diniz; Manoj Kumar Jaiswal; Kurt A Jellinger; Lev S Kruglov; Ivan A Meshandin; Milija D Mijajlovic; Guenter Niklewski; Sarah Pospos; Keerthy Raju; Kneginja Richter; David C Steffens; Warren D Taylor; Oren Tene
Journal:  BMC Med       Date:  2016-11-03       Impact factor: 8.775

5.  Contributions of cardiovascular risk and smoking to chronic obstructive pulmonary disease (COPD)-related changes in brain structure and function.

Authors:  Catherine A Spilling; Mohani-Preet K Bajaj; Daniel R Burrage; Sachelle Ruickbie; N Jade Thai; Emma H Baker; Paul W Jones; Thomas R Barrick; James W Dodd
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-08-21

6.  Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.

Authors:  Christian Puzo; Caroline Labriola; Michael A Sugarman; Yorghos Tripodis; Brett Martin; Joseph N Palmisano; Eric G Steinberg; Thor D Stein; Neil W Kowall; Ann C McKee; Jesse Mez; Ronald J Killiany; Robert A Stern; Michael L Alosco
Journal:  Alzheimers Res Ther       Date:  2019-07-27       Impact factor: 6.982

Review 7.  Pathomechanisms of Vascular Depression in Older Adults.

Authors:  Kurt A Jellinger
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.